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When challenged by difficult biological samples, the forensic analyst is far more likely to 
obtain useful data by sequencing the human mitochondrial DNA (mtDNA).  Next-
generation sequencing (NGS) technologies are currently being evaluated by the Forensic 
Science Program at Western Carolina University for their ability to reliably detect low-
level variants in mixtures of mtDNA.  The sequence profiles for twenty individuals were 
obtained by sequencing amplified DNA derived from the mitochondrial hypervariable 
(HV) regions using Sanger methods.  Two-person mixtures were then constructed by 
mixing quantified templates, simulating heteroplasmy at discrete sites and in defined 
ratios.  Libraries of unmixed samples, artificial mixtures, and instrument controls were 
prepared using Illumina® Nextera® XT and deep-sequenced on the Illumina® MiSeq™.  
Analysis of NGS data using a novel bioinformatics pipeline indicated that minor variants 
could be detected at the 5, 2, 1, and 0.5% levels of detection.  Additional experiments 
which examined the occurrence of sequence variation in hair tissue demonstrates that a 
 
 
considerable amount of sequence variation can exist between hairs and other tissues 
derived from a single donor. 
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CHAPTER ONE:  BACKGROUND 
Section 1.1:  The biology of mitochondrial DNA and its relevance to forensic casework 
 There are hundreds of mitochondria within each nucleated cell of human body 
(Robin & Wong 1988).  Visualizations of DAPI-stained mitochondrial DNA (mtDNA) in 
a human ovarian cancer cell line indicated a range of 1 to 15 copies of mtDNA per 
mitochondrion (Satoh & Kuroiwa 1991).  This gives an estimated range of hundreds to 
thousands of copies of mtDNA per cell and an average of approximately five hundred 
copies of mtDNA molecules in cells comprising most somatic tissues (Satoh & Kuroiwa 
1991).  Since mtDNA is present in high copy number and possesses an exonuclease 
resistant, circular structure (see Figure 1), the likelihood of its recovery from biological 
evidence is significantly higher than its nuclear counterpart (DiZinno et al. 1999) and is 
the preferred molecule for analysis when extracting from challenging sample types which 
likely contain nuclear DNA that is either highly degraded or nonexistent.  Such samples 
would include naturally shed hairs, aged teeth, and bone material. 
 The sequencing of mtDNA from evidentiary material is a valuable asset to the 
forensic scientist.  Forensic analysts sequence amplicons, or amplified DNA, derived 
from the human mitochondrial control region (CR) to obtain useful data (Wilson et al. 
1995a).  The CR is a noncoding region of the mitochondrial genome and is of particular 
interest to forensic scientists because of the frequency of variants, including single 
nucleotide polymorphisms (SNPs) which occur there.  These variants enable the analyst 
to identify a haplotype within the different mitochondrial lineages of the human  
13 
 
 
 
Figure 1 – Illustration of the human mitochondrial genome (Butler 2011).  The hypervariable regions of the Control Region (CR) are 
indicated by the shaded regions entitled ‘HV1’ (16024-16365) and ‘HV2’ (73-340). 
population (DiZinno et al. 1999).  In forensic contexts, the utility of mtDNA sequence 
interpretation includes:  the elimination of possible contributors of source material, 
establishing investigative leads in cases regarding missing persons, tracing maternal 
lineages among the human population, and aiding in the reassociation of a victim’s 
remains after a mass disaster or armed conflicts.  Forensic casework places a clear 
objective of obtaining meaningful results that meet the rigorous standards of quality 
assurance.  The workflow used by crime labs in order to obtain mtDNA sequence data is 
presented in the grayed flowchart shown in Figure 2.  Interpretations of mtDNA sequence 
data cannot however, be used to establish the absolute identity of its biological 
contributor, a consequence of its mode of inheritance.   
 The inheritance of mtDNA haplotypes are largely influenced by the maternal 
contribution to the developing zygote (Hutchinson et al. 1974).  Explanations for this 
mode of inheritance include a stark numerical difference in the mtDNA copy numbers of 
oocytes relative to sperm cells (Chen et al. 1995, Hecht et al., 1984) and a ubiquitin- 
14 
 
 
Figure 2 – Branched workflow of Sanger and next-generation sequencing methods for generating mitochondrial sequence data. 
dependent proteolysis pathway that is implicated in the targeted degradation of paternally 
derived mitochondria and concomitant mtDNA (Sutovsky et al. 2003).  Though 
exceptions to complete maternal transmission have been reported (Schwartz & Vissing 
2002), mtDNA haplotypes are highly conserved from one maternal generation to the next 
and explains why the same mtDNA haplotype is observed across maternal siblings and 
other maternal relatives. 
 Heteroplasmy is the presence multiple mtDNA haplotypes within an individual 
and it has been observed in two distinct forms:  as sequence (Gill et al. 1994, Ivanov et al. 
1996, Wilson et al. 1997) and as length heteroplasmy (Pfeiffer et al. 2004).  Sequence 
heteroplasmy can be observed when two or more nucleotides are present at a single base 
position.  Length heteroplasmy can be observed when two or more different lengths of a 
homopolymeric C-stretch are present within the mtDNA sequence.  Since the first 
documented occurrence of the phenomenon within a forensic context (Gill et al. 1994, 
Ivanov et al. 1996), heteroplasmy has merited numerous scientific inquiries.  In an 
experiment to determine the interpretive limit for denaturing gradient-gel electrophoresis 
(DGGE) systems, the authors prepared mixtures of mtDNA for analysis (Tully et al. 
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2000).  The threshold for mixture detection on DGGE was found to be approximately 
1%.  Using DGGE and amplicons derived from human mitochondrial hypervariable 
region 1 (HV1), the authors were able to detect low levels of heteroplasmy in 13.8% of 
its sample population of unrelated individuals (n=253), demonstrating that heteroplasmy 
is not uncommon.  Additionally, the authors found that by using DGGE, heteroplasmy 
could be discerned at 16 different locations within HV1, that it occurred as both sequence 
and length variants, and that two donors exhibited triplasmy, a condition in which 
heteroplasmy occurs at two different locations within an individual.  Given that mtDNA 
has shown higher mutation rates than nuclear DNA (Bogenhagen 1999), which is likely 
attributed to fewer DNA repair mechanisms and an inability of the mtDNA polymerase to 
proofread (Kunkel 1981), lends credence to the idea that trillions of mtDNA copies are 
not likely to share a single, uniform mtDNA sequence. 
 In humans, ovulation results in one or more mature oocytes are released from an 
ovarian follicle.  If fertilized, the degree to which heteroplasmy occurs in these progenitor 
cells, whether high, low, or non-existent, will largely influence the degree of 
heteroplasmy observed in resulting progeny.  Genetic bottlenecks such as these (Figure  
 
Figure 3 – Reduction of mtDNA haplotypes as a result of a genetic bottleneck (Arrows) in the parental (Center) that appears 
homoplastic for a particular base position.  Minor variant in parental population is denoted as G.  (Left) A moderate degree of allelic 
drift results in progeny that are heteroplasmic in appearance.  (Right) A wide degree of allelic drift results in progeny that appears 
homoplastic for the minor variant, which has become the major component of a mixed population. 
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3), in which a large population is culled to a few representative types, can have a 
profound impact on observed population structure and may explain why single base 
differences have been observed across parent and progeny (Parsons et al. 1997).  These 
base substitutions and the rate at which they approach fixation within a population of 
individuals, forms the basis for human mitochondrial evolution.  While the implications 
of this are significant from an evolutionary perspective, of more relevance to the 
situations encountered during forensic casework is that a similar bottleneck event is 
expected to occur during the histogenesis of hair. 
 The growth and replacement of hair tissue is fairly complex.  The cells that feed 
the emerging hair follicle represent a small, clonally propagating population (Linch et al. 
2001).  Unlike other tissues, hair emerges from the body; when these cells die, they are 
not reabsorbed.  Therefore, the mtDNA extracted from hair shafts is expected to reflect 
the heteroplasmic content of the original population of cells which propagated from the 
follicle.  Similar to the bottleneck event that occurs during oogenesis, the reduction of the 
mtDNA copies to a smaller representative population has the potential to cause a wide 
degree of sequence variation.  This is believed to be the biological explanation for the 
wide degree of sequence variation observed across multiple hair samples collected from a 
single donor in comparison to other, more homogenous tissue types (Wilson et al. 1997), 
as well as in studies of mtDNA length variants observed in sub-cloned hair extracts of 
monozygotic twins (Pfeiffer et al. 2004).  This research underscores the potential benefit 
of technologies that can more accurately resolve low-level mixtures of human mtDNA.  
The ability to resolve minor variations, or low-level mitochondrial haplotypes within a 
mixed population of mtDNA molecules, is dependent on the sequencing chemistry and 
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the resolution power of the process.  Current methods of mtDNA sequencing utilize 
Sanger sequencing and capillary electrophoresis. 
Section 1.2:  Overview of chain-terminating sequencing and capillary electrophoresis 
 The dideoxy chain-terminating chemistry used by BigDye® Terminator v1.1 
Cycle Sequencing Kit (Applied Biosystems 2002) and similar kits generate DNA 
fragments of varying lengths, each with a base specific fluorophore attached.  The 
cyclical process of deoxynucleotide triphosphate (dNTP) incorporation into every 
position of the extending DNA chain is similar to PCR but instead of only incorporating 
dNTPs, a dideoxynucleotide triphosphate (ddNTP) may be incorporated by chance.  The 
chemistry of ddNTP incorporation is demonstrated in Figure 4.  These ddNTPs lack a 
hydroxyl group on the 3’ carbon of the sugar moiety.  Without this 3’ hydroxyl group, the 
polymerase cannot induce the phosphodiester bond needed to link one nucleotide to the 
next, and extension of the DNA chain will cease.  The terminating ddNTP at the 3’-end 
of these fragments has a covalently attached base specific fluorophore, which is an 
attached moiety capable of absorbing a photon, enabling fluorescence upon relaxation.   
 
 
Figure 4 – During cycle sequencing, a ddNTP lacking the 3’ hydroxyl group may be incorporated into the growing nucleotide chain.  
Without its hydroxyl moiety, the 3’ carbon lacks the nucleophile needed to interact with the phosphate group of the next dNTP, 
effectively terminating DNA extension.  Not shown:  polymerase and the covalently attached fluorophore on the ddNTP. 
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Figure 5 – Simplified illustration of Sanger sequencing products.  Forward and reverse primers would be separated into different 
centrifuge tubes to keep forward and reverse amplicons from mixing.  Circles and squares represent chain terminating ddNTPs.  In this 
example, the forward sequence would be read 5’-GTCCAG-3’ and the reverse sequence would be read as 5’-ACGGAT-3’. 
The result of this sequencing chemistry is a collection of single stranded DNAs, of 
varying lengths, where each fragment is covalently bound to a base specific fluorophore 
of the last base incorporated.  The products of this reaction are depicted in Figure 5.
 After these fragments are cleaned of residual ddNTPs, vacuum centrifuged and 
resuspended in Hi-Di™ formamide, the cycle sequencing products are run on the Applied 
Biosystems® 3130xl Genetic Analyzer.  This and other capillary electrophoresis 
instruments can separate single stranded DNA products by size (Applied Biosystems 
2004).  As the negatively charged DNAs of the sequencing reaction separate through a 
capillary array filled with a polymer matrix that acts as a sieving medium, fragments of 
increasing size pass through a detection window sequentially.  There, the fragments are 
exposed to an argon laser which excites the base specific fluorophore of the terminating 
ddNTP and as the fluorophore relaxes, it emits a wavelength of light specific to the last 
base incorporated.  This fluorescence is captured by a charged coupled device (CCD) 
camera.  The interval at which light data is collected is then converted into an 
electropherogram peak, where the different wavelengths of light are represented by a four 
color scheme and their associated intensities are measured in relative fluorescence units 
(RFUs).  Put succinctly, time and fluorescent emission data are used to determine the 
base-by-base sequence of the DNA template. 
19 
 
 
Figure 6:  Chromatograms for sequence data obtained from HV1a  and HV1b of donor 006-CM25Blood.  These chromatograms were 
visualized using Sequencher v4.8, a sequence visualization software.  The second chromatogram has a ‘noisy’ baseline. 
 While the use of chromatograms have been and, for the immediate future, will 
continue to provide useful information to forensic examiners, the peaks are however, not 
quantitative—peak height cannot be correlated to an exact number of DNA molecules 
that gave rise to it (Parker et al. 1995, Parker et al. 1996).  This means that interpretation 
of potentially heteroplasmic samples is somewhat of an art, whereby forensic examiners 
must be trained to distinguish true mixtures above the baseline noise of the instrument.  
In instances where chromatograms have ‘noisy’ baselines, a low-level mixture is less 
likely to be called with confidence.  Experimentally, the limit of resolution for capillary 
electrophoresis instruments in their ability to correctly call a mixed position by forensic 
examiners has been demonstrated to be approximately 10% (Wilson et al. 1995b), falling 
well above the reported sensitivities of other, non-sequencing forms of analyses 
(Underhill et al. 1999, Tully et al. 2000). 
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Section 1.3:  Mitochondrial sequence interpretation in forensic casework 
 Sequence analysis of mtDNA in forensic casework involves comparing question 
samples (Qs), samples whose biological contributor(s) are unknown, to known samples 
(Ks), in which the contributor is known.  Trained forensic examiners make direct 
observations of resulting mtDNA sequence data, which is in chromatogram format.  
Resultant sequences for Qs and Ks are directly compared to one another and the sequence 
differences are noted.  Figure 7 gives an example of how Qs and Ks are compared.  In  
 
Figure 7 – Hypothetical sequence data for Qs and Ks.  A) Q and K have the same base at every position.  B) Q and K have a shared 
base at every position and a shared base at the underlined position.  C) Q and K have a single base difference at the underlined 
position.  D)  Q and K have two bases that differ at the underlined positions. 
example 7a, there is a common base at every position within the sequence window.  In 
example 7b, the K indicates that both cytosine and thymine are observed at the 
highlighted position and no contamination is suspected.  Since thymine is observed at the 
indicated position in both Q and K, the sequences are concordant.  In example 7c, there is 
a single base difference between the Q and K, and in example 7d there are two base 
differences.  Conceptually, the interpretations of the various insertions/deletions that 
occur around the C-stretch region of HV2 are no different.  Consider the sequences 
presented in Figure 8.  In example 8a, the Q and K have the same number of cytosine 
residues.  In example 8b, the Q has a C-stretch type (C8TC6) that is shared with the K, 
which shows length variants (C8TC6/C9TC6).  Example 8c has a single base 
21 
 
 
Figure 8 – Hypothetical sequence data for Qs and Ks.  A) Q and K have the same base at every position.  B) Q and K have a shared C-
stretch haplotype.  C) Q and K have a single have a single difference within the C-stretch region.  D)  Q and K have two differences 
within the C-stretch region. 
difference and 8d has two base differences.  To interpret observed sequence differences 
in routine casework, the Scientific Working Group on DNA Analysis Methods 
(SWGDAM 2003) suggests these guidelines be followed: 
• Exclusion – if there are two or more nucleotide differences between the 
questioned and known samples, the sample can be excluded as originating 
from the same person or maternal lineage. 
 
• Inconclusive – if there is one nucleotide difference between the questioned 
and known samples, the result will be inconclusive. 
 
• Failure to Exclude – if the sequences from questioned and known samples 
under comparison have a common base at each position or a common length 
variant in the HV2 C-stretch, the samples cannot be exclude as originating 
from the same person or maternal lineage.  
Assuming that no other differences occur outside the sequence windows that are 
presented in Figures 7 and 8, and using the SWGDAM guidelines for interpretation, the 
forensic examiner would not be able to exclude the known profile as a possible 
contributor for the questioned sample in examples 7a, 7b, 8a, and 8b.  For the indicated 
examples, they would reach a conclusion of failure to exclude.  For 7c and 8c, the 
conclusion would be inconclusive and for 7d and 8d, an exclusion would result.   
 A short-hand notation for describing sequence differences aligns questioned and 
known sequences against the revised Cambridge Reference Sequence (rCRS), a standard 
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reference sequence of human mtDNA (Anderson et al. 1981, Wilson et al. 1995a).  
Differences between the samples and the rCRS are described using the positions and the 
respective bases in which they differ, as demonstrated in Figure 9.  These notations are 
used when documenting the observed differences between collected samples, when 
uploading reference sequences into the forensic mtDNA database, and when cross-
referencing the rarity of an observed mtDNA haplotype against those stored in the 
database. 
 The common mtDNA sequence found in the Q/K samples is compared to a 
mtDNA population database.  These databases allow the forensic scientist to derive a 
weight assessment of the association.  Conveying this estimate of rarity involves counting 
the number of times a particular haplotype is observed within the DNA database among 
the different defined subsets of the human population and applying a 95% upper-bound 
confidence interval to this calculation (Wilson et al. 1993, Holland & Parsons 1999).  As 
such, the strength of this assessment is based on the number of profiles within the 
database, the current estimates for which are approximately 15,000 profiles and growing 
(Parson & Dür 2007, Melton et al. 2012).   
 
Figure 9 – Comparison of hypothetical sequence alignments (Butler 2011). A) Question and known samples aligned beneath the 
reference sequence.  B) Short-hand notation for reporting differences. 
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Section 1.4:  The Illumina® MiSeq™ 
 Next-generation sequencing (NGS) technologies have introduced new methods of 
DNA sequencing.  While capillary electrophoresis instruments are designed to generate a 
sequence from a population of DNA fragments arising from a single amplicon, NGS 
technologies provides sequence data from millions of individual DNA molecules in 
parallel.  Shared among all NGS platforms are (1) the immobilization of DNA molecules 
to a medium, separating them in space, and (2) the clonal amplification of the progenitor 
molecule to increase signal intensity.  Beyond that, each platform has its own unique 
method of sequencing, and these emerging methods have dramatically reduced the time it 
takes to sequence DNA by increasing the amount of data obtained in each individual run, 
which also allows multiple donors to be sequenced in tandem.   
 With the advent of massively parallel sequencing technologies, it is possible to 
resolve and quantify mixtures of mtDNA (Bintz et al. 2013, Andréasson et al. 2006a) as 
well as broaden the sequencing breadth to areas outside the CR (Andréasson et al. 
2006b).  New extraction techniques that optimize the recovery of mtDNA from hair 
shafts (Burnside et al. 2013) and the development of whole genome amplification (WGA) 
techniques (Qiagen® 2011) may even make it feasible to routinely deep sequence the 
entire mtGenome from short hair fragments.  These implications make next-generation 
sequencing technologies attractive to forensic science as their implementation could 
significantly impact the future of mtDNA analysis. 
 The Illumina® MiSeq™ is a sequencing-by-synthesis instrument currently 
housed in the Forensic Science DNA sequencing facility at Western Carolina University.  
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This platform utilizes a unique sequencing chemistry and a proprietary, optically 
transparent flow cell, covered in a dense lawn of oligonucleotide anchors (Bentley et al. 
2008, Illumina® 2012a).  Prepared single stranded template molecules hybridize to the 
flow cell bound oligonucleotides if they contain the complementary adapter sequence.  
These adapters are designed to be randomly incorporated into the DNA template to be 
sequenced during Nextera® XT processing, an enzymatic sample preparation step 
(Caruccio 2011, Illumina® 2012b).   
 Nextera® XT ‘tagments’ dsDNA by randomly fragmenting it into varying lengths 
and ligating oligonucleotide tails onto these fragments, which then serve as priming sites 
for a limited cycle PCR (Figure 10).  This step incorporates the bidirectional indices and 
adapter sequences needed to bind template molecules to the flow cell.  The bidirectional 
indices are analogous to a genetic barcode which can allow for the bioinformatic parsing 
of sequence data belonging to a particular individual or treatment.  After PCR, a library  
Amplicon TemplateA B A B
A B A B
Amplicon Template
A B A BAmplicon Template
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Figure 10 – Illustration of how Nextera® XT prepares template molecules for sequencing (Illumina® 2012).  (1) Transposons are 
introduced to template molecules and (2) bind to templates at random locations.  (3) The enzymatic fragmentation of DNA templates 
incorporates forward and reverse adapter sequences.  (4) Adapter sequences are the targets of a limited cycle PCR which incorporates 
the flanking index and adapter sequences. 
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purification step using solid phase reversible immobilization (SPRI) beads in the 
presence of polyethylene glycol (PEG) and a salt buffer will effectively remove 
unincorporated PCR primers and short (<100 bp) fragments from solution without any 
need for gel electrophoresis size separation (DeAngelis et al. 1995).  Removal of short 
fragments is critical because they can compete for space on the flow cell.  Upon clean-up, 
a normalization step dilutes the libraries to a desired concentration.  By the end of sample 
preparation, the pooled amplicon library contains sodium hydroxide which keeps the 
library single stranded.  Samples are then loaded onto the MiSeq™ reagent cartridge for 
on-board cluster generation and subsequent deep sequencing.   
 When flowed through the flow cell, single stranded template molecules will 
hybridize to the lawn of primers bound to the flow cell.  These individual single stranded 
templates are then clonally amplified via on-board cluster generation, which is depicted 
in Figure 11.  Clonal amplification, sometimes referred to as ‘bridge amplification,’ 
begins with washing NaOH from the flow cell, lowering the pH of the environment so  
1)
2) 3)
4)
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Figure 11:  Summary of cluster generation (Bentley et al. 2008).  1) Single stranded template hybridizes to its complementary 
oligonucleotide anchor.  2) Polymerase and dNTPs are flowed over the flow cell to synthesize the template complement.  3) NaOH is 
flowed over the flow cell to denature DNA—only DNA complements anchored to the flow cell will remain.  4) NaOH is washed 
away, allowing DNA to hybridize to a complementary oligonucleotide anchor that is in close proximity forming a DNA bridge.  
Polymerase and dNTPs are flowed over the flow cell to synthesize to extend the bridge strand.  5) NaOH is flowed over the flow cell 
to denature the DNA bridge.  6) Repetitions of steps 4 and 5 will result in a bidirectional cluster of DNA derived from a single 
template molecule.  7) Enzymatic cleavage of an anchoring adapter sequence will leave products of a unidirectional flow. 
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that the complementary strand may be synthesized to the oligonucleotide anchor.  The 
reverse adapter sequence is synthesized as well.  A second denaturation wash with NaOH 
allows for the separation of the progenitor template molecules from their complements 
that are now covalently bound to the flow cell.  Removal of NaOH will then allow the 
reverse adapter on the newly synthesized complement to hybridize to another 
oligonucleotide anchor, creating a DNA bridge.  This bridge creates the primer-template 
complex, to which polymerase can be recruited for extension of the nucleotide chain.  
Repeated processes of denaturation, annealing, and extension will create clusters 
containing approximately two thousand clonal molecules. 
 Sequencing on the Illumina® MiSeq™ uses the proprietary TruSeq™ family of 
reagents.  The TruSeq™ design utilizes specialized fluorescently labeled, chain 
terminating dNTPs.  These reversible terminating dNTPs have a base-specific fluorescent 
moiety and 3’-O-azidomethyl blocking group, both of which are removed in the presence  
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Figure 12:  Sequencing using the TruSeq™ family of reagents (Bentley et al. 2008).  (Left) Reversible terminating dNTPs are washed 
across the flow cell after the hybridization of a sequencing primer.  Adenosine matches its complement and extends the sequencing 
chain by one base.  (Middle) Clusters are excited by light causing the emission of light by the base specific fluorophore which is then 
recorded by the instrument.  The fluorophore and 3’-blocking group are enzymatically cleaved, allowing the extension of the 
sequencing chain.  (Right) Iterative cycles of base incorporation, excitation, recording, and deprotecting result in the bound template 
sequence. 
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of tris(2-carboxyethyl)phosphine (TCEP), not only flushing out the fluorescent dye of the 
previously incorporated dNTP but also enabling incorporation of the next nucleotide in 
sequence (Milton et al. 2004, Bentley et al. 2008).  In the first step of sequencing, clusters 
are denatured and the reverse strands are eliminated by a cleavage reaction.  This leaves 
bound templates of unidirectional flow.  Sequencing is initiated, first, by hybridizing a 
sequencing primer specific to index 1 of the bound template molecules.  Then, 
polymerase incorporates a single dNTP into the growing chain.  Excess reagents are 
washed away and laser excitation of the newly integrated fluorophores causes emission of 
light at wavelengths specific to the base incorporated.  This initial detection of light helps 
identify DNA clusters.  The instrument gives each cluster a unique Cartesian coordinate 
based on this location within the flow cell.  Base calling is achieved by calculating the 
signal intensities generated by each cluster.  Once recorded, the fluorophore and the 3’ 
blocking group on the chain terminating dNTP are chemically cleaved with TCEP and 
the 3’ hydroxyl group is simultaneously regenerated, allowing the nucleotide chain to 
extend.  Six additional cycles of single dNTP incorporation, washing excess dNTPs 
away, reading the signal intensities at specific Cartesian coordinates, and then cleaving 
the fluorophore allows the Illumina® MiSeq™ to record the forward index sequence of 
bound templates.  Once the indexing cycle is completed, the indexing primer and 
associated reads are denatured and washed off the flow cell.  A second sequencing primer 
is then flowed into the flow cell and hybridizes to template molecules at a position 
upstream of DNA template.  Again, the cyclic repetition of dNTP incorporation, washing 
excess dNTPs away, recording signal intensities, and then cleaving the fluorophore 
allows the instrument to sequence up to 150 bases of each individual DNA cluster.  
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Figure 13:  Summary of paired-end turn-around (Bentley et al. 2008).  (Left) Single molecule representation of the event.  (Right) 
Cluster representation of the event.  1) After ‘Read 1’ sequencing ends, NaOH is flowed across the flow cell to denature the 
sequencing primer and associated bases.  2) Removal of NaOH allows for the ‘DNA bridge’ to form.  Extension is achieve one base at 
a time.  When the sequence has extended to the reverse index, the index is sequenced and recorded.  3) After the reverse index is 
sequenced, the reverse strand is fully synthesized.  Forward and reverse strands are made single stranded with NaOH.  4) The forward 
strand is enzymatically cleaved, leaving only the reverse strands.  ‘Read 2’ sequencing primer hybridizes and the reverse strand is 
sequenced. 
 Paired-end turn-around is the process by which clusters sequenced during the first 
set are inverted by one cycle of bridge amplification, in effect, synthesizing the reverse 
strand.  For greater clarity, Figure 13 presents a diagram of this event in both a single 
molecule and a cluster format.  After the sequencing the forward read, the sequencing 
strand is denatured from anchored template molecules by flowing NaOH through the 
flow cell.  Removal of NaOH allows anchored templates to hybridize to a nearby, 
complimentary anchor, creating the DNA bridge.  The reverse complement is synthesized 
with the TruSeq™ reversible terminating dNTPs.  This ‘dark cycle’ records no images.  
Instead, it extends the complement strand in well-controlled, incremental steps.  This 
extends the newly synthesized chain to be adjacent to the reverse index.  Once the chain 
reaches the appropriate length, the reverse index is sequenced and recorded.  When a 
cluster has both its forward and reverse indices sequenced, it is given its identity.  Upon 
sequencing the reverse index, unlabeled dNTPs and polymerase are flowed across the 
flow cell, fully synthesizing the complementary, reverse strand.  After the reverse strand 
is synthesized, the forward reads are enzymatically cleaved and removed from the flow 
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cell, leaving only templates of a reverse directionality.  A third primer is then hybridized 
to the template molecules and sequencing will commence in the reverse direction. 
 An optimized run on a v1 flow cell can achieve over five million clusters from 
which to derive sequence data.  New iterations of flow cells can achieve 3 times that 
number and new kits can sequence 100 bases further in each direction.  This depth of 
coverage is achieved by the paired-end sequencing of millions of DNA clusters derived 
from single template molecules, in parallel, coupled with the ability to parse individual 
treatments from a mixed library.  This process allows a forensic analyst to scrutinize 
mtDNA sequence data from many individuals, at a degree of resolution that could not be 
previously achieved.  However, before it can be determined that an observed minor 
variant is above threshold, it is required to necessary to establish the limits of detection of 
minor variants. 
Section 1.5:  Intentions of research 
 Given the limits of detection of traditional Sanger sequencing, subtle mixtures of 
mtDNA may not be detected.  With the advent of next-generation sequencing 
technologies, like the Illumina® MiSeq™, not only will it be possible to detect minor 
variants with greater reliability from single and multi-source samples but it will also offer 
forensic science benefits that are beyond the scope of this project.  Beyond resolving low-
level variants, deep sequencing may also (1) sequence entire mtGenomes in order to 
identify SNPs which occur outside the CR, (2) substantially decrease the time it takes to 
interpret sequence profiles, and (3) optimize processing sizes in a manner that is both 
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time and cost efficient and subsequently, (4) may allow for the rapid generation of larger 
mtDNA databases to support forensic casework analyses. 
 This research seeks to evaluate the Illumina® MiSeq™ for mtDNA sequencing 
analysis.  It will experimentally determine at what level of resolution this instrument 
detects minor variants in mixed samples of mtDNA.  It will also discern the degree of 
sequence variation that can be observed, if any, across forensically relevant tissue types.  
Before performing these experiments, it will be necessary to obtain CR reference profiles 
for twenty individuals using the traditional methods of cycle sequencing and capillary 
electrophoresis on an Applied Biosystems® 3130xl Genetic Analyzer.  With this Sanger 
data, candidates will be selected for two person mixtures.  Using blood and buccal 
extracts, the four HV amplicons will be amplified using a high fidelity polymerase in 
order to minimize the occurrence of polymerase induced sequence misincorporation.  
After these amplicons are quantified, artificial mixtures will be prepared using two 
donors at four levels of resolution—5, 2, 1, and 0.5%—in order to simulate a biological 
mixture at discrete sites and in defined ratios.  These samples will then be prepared for 
sequencing on the Illumina® MiSeq™ and an analysis of produced sequence data will  
 
Figure 14 – Branched workflow of Sanger and next-generation sequencing methods for generating mitochondrial sequence data. 
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focus on the effects of alignment strategies, filtering regimes, potential sources of noise, 
setting statistical thresholds, and minor variant interpretation.  This project will also 
perform an analysis of sequence data derived from hair samples by comparing CR 
sequence data produced from five different hair samples against the CR sequence data of 
a buccal extract from selected donors.  Data analysis will focus on alignment strategies, 
filtering regimes, potential sources of noise, setting statistical thresholds for data 
interpretation, and minor variation. 
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CHAPTER TWO:  BIOINFORMATICS 
Section 2.1:  Conclusions from the mixture experiment performed on the Illumina® 
Genome Analyzer IIx. 
 The major conclusions drawn from an early mixture experiment on the Illumina® 
GAIIx were that (1) the targeted sequencing of amplicons, as opposed to fragmented 
genomes, hinders basecalling accuracy and that (2) the on-board variant calling software 
could not confidently call minor variants in mixtures of mtDNA.  A fully balanced 
genome is one in which there is an equal distribution of the four bases at every cycle of 
sequencing (Illumina® 2012a).  This is important for Illumina® based platforms because 
these instruments produce high resolution .TIF images in order to record base-specific 
fluorescence.  At the time it was believed that modified primers, shown in Figure 15, 
which incorporated flanking adapters and the specific index sequence could bypass the 
need for a genomic shearing device.  Instead, it created an unbalanced genome.  For 
unbalanced genomes, like those produced during targeted amplification, sequencing 
begins at the same position across all template molecules.  When combined with 
templates that have a high degree of sequence homology, the resulting .TIF images are  
  
Figure 15:  Modified primer design used to create templates ready for sequencing on the Illumina® GAIIx.  The targeted deep-
sequencing of amplicons prepared in this method generated unbalanced genomes. 
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saturated with the fluorescence of a single base at every cycle of sequencing.  Illumina® 
instruments are not prepared for this and a subsequent decrease in basecalling confidence 
is observed.  The development of Nextera® XT, which prepares templates by 
enzymatically fragmenting them at random locations, resolved the issue of library 
balance and greatly improved the quality of subsequent runs.  Variant analysis however, 
necessitated the development of a novel bioinformatics pipeline.  
Section 2.2:  Quality scores and the development of a novel bioinformatics pipeline for 
paired-end datasets 
 Bioinformatics is a field of study dedicated to the analysis of data produced by 
molecular biology using computational science.  It has coevolved and expanded in its 
utility with the recent advancements in biotechnology and offers many methods of 
analysis.  The bioinformatics pipeline developed for this project is a series of steps that 
will analyze NGS datasets by demultiplexing mixed datasets, treating the data to preserve 
the best quality data, aligning the sequence data against the reference of interest, and may 
then offer some visualization of the reads against an aligned reference and report their 
respective basecalls and quality scores.   
 During sequencing on the Illumina® MiSeq™, each cluster is given a unique 
cluster identifier.  If the instrument has confidence that it is recording data from a single 
cluster, the cluster ‘passes filter.’  Only clusters that pass filter record sequence data and 
corresponding base quality.  The data is recorded in the .fastq file format, an example of 
which is presented in Figure 16.  Individual .fastq files are separated by the instrument 
according to the two indices selected and defined by the user prior to sequencing.  If a  
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Figure 16:  An entry of the .fastq file type.  (Top) Cluster identifier, stating its unique Cartesian coordinate.  (Middle) The base 
sequence derived from sequencing the DNA cluster.  (Bottom) ASCII code expressing respective base quality.  For example, the 
ASCII code ‘?’ = Q30, ‘A’ = Q32, and ‘I’ = Q40. 
paired-end run is performed, sequence information belonging to a particular index 
combination is further sub-divied into forward and reverse .fastq files.  Since a cluster is 
sequenced in both forward and reverse directions, the unique cluster identifier appears in 
the corresponding forward and reverse .fastq files.  These entries also pair each base of 
sequence data with a single character ASCII symbol.  These symbols are a method of 
conveying the quality scores (or Q-scores) of the phred-based quality scoring language of 
basecall accuracy.  A Q-score is a shorthand notation of the probabilistic model used to 
assess bascalling error.  Illumina® has adopted the phred scale for representing the base 
quality of sequence data.  The phred-based algorithm used by most Sanger compatible 
software was designed to not only predict peaks for base calling but also to derive a 
statistic that estimates the probability of error (Ewing and Green 1998, Applied 
Biosystems 2002).  This estimate of basecalling accuracy is expressed using the formula 
QV = -10log10(Pe), where QV is the presented quality value (Q-score) and Pe is the 
probability of error.  Given a QV of 10, the probability of a basecall being inaccurate is 1 
in 10; given QV = 20, 1 in 100.  Though differing from Sanger based calculations of Pe, 
Illumina® platforms still perform the log10-transformation of Pe to express base quality. 
 Quality scores can be used to filter and trim large datasets.  The datasets that NGS 
platforms produce are large enough that the analyst can afford to remove sequences of 
poor quality, thus preserving only the best quality data and reducing the time it takes to 
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align files to the reference of interest.  There are many different methods of filtering and 
trimming datasets, some are more suited for one experimental design as opposed to 
others.  In particular, a large portion Illumina® sequence reads suffer from a noticeable 
drop in Q-scores as sequencing progresses.  After paired-end turn around occurs and the 
second sequencing primer hybridizes to the reverse strands, the quality scores of the new 
sequencing strand start with high confidence and gradually drops in average Q-score as 
sequencing progresses.  Therefore, in Illumina® datasets, the data of poorest quality in 
both forward and reverse sequence reads, is generally located on the 3’-end of the reads.   
 Initially, a bioinformatics pipeline was developed for single-read data produced 
by the Illumina® GAIIx using Galaxy™, a free to use cloud-computing bioinformatics 
service that allows its users to build customizable analysis pipelines for data processing 
(Giardine et al. 2005, available at www.galaxyproject.org).  This pipeline filtered datasets 
in various ways, visualized the effects of various filtering regimes on overall sequence 
quality, aligned filtered sequence data against the rCRS, generated data pileups and 
filtered those pileups by Q-score and coverage to perform variant analysis.  While the 
results for this initial mixture study were promising (data not shown), demonstrating that 
minor variants could be detected in mixtures of human mtDNA down to the 5, 2, 1, and 
0.5% levels of resolution, the generated data was derived from a sequencing run that 
experienced numerous errors and the data was therefore, abandoned.  It did however 
prove, in principle, that the sequence data obtained from Illumina® platforms could be 
treated in a similar fashion to produce accurate variant calls.  The initial bioinformatics 
pipeline was then modified to accommodate the effects of paired-end sequencing for data 
produced by the Illumina MiSeq™ (see Figure 17). 
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Figure 17 – An abridged version of the bioinformatic pipeline used to assess minor variants in the Illumina® MiSeq™ datasets.  
Alignment with BWA paired-end aligns the different sets of read data—forward and reverse—into a single alignment file. 
 Associated forward and reverse .fastq files are uploaded to the Galaxy cloud and 
groomed so that the data to could be filtered.  Grooming converts the variety of phred 
scoring formats that exist among competing sequencers into a common quality scoring 
language, allowing the service to filter datasets from a variety of platforms (Blankenberg 
et al. 2010).  Grooming MiSeq™ .fastq files converts the files to the ‘fastqsanger’ quality 
scoring format in which Q-scores have a range of Q0 to Q40.  Both forward and reverse 
sequences reads were then filtered using the ‘Filter by quality’ function of the FASTX-
toolkit in order to remove poor quality reads (Gordon & Hannon n.d.).  This method of 
filtering retains reads which have >Q20 over 90% of the base composition.  The rCRS 
was then uploaded to the workspace in a .fasta format (no associated Qscores) and used 
as a reference file for alignment of filtered reads.  Filtered reads were then aligned to the 
rCRS using the default alignment parameters of the Burrows-Wheeler alignment (BWA) 
tool for paired-end data.  The BWA alignment tool was selected as opposed to competing 
alignment algorithms because experimentally, it had been demonstrated that BWA can 
align millions of sequence reads with a higher percentage of confidently mapped reads 
(reads that have a lower probability of being mapped incorrectly) and lower error rates 
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(when confidently mapped reads are inappropriately aligned) than its competitors (Li & 
Durbin 2009).  BWA alignment produces a file in SAM (Sequence alignment map) 
format.  Following alignment, tabular datasets can be generated from SAM files using the 
‘Generate Pileup’ function of SAMtools (Li et al. 2009).  These data pileups present a 
subset of the base positions within the reference genome where sequence reads have 
aligned, showing the number of reads that have aligned over a particular position of the 
reference (coverage) and the overall base composition with respect to aligned reads.  Data 
pileups could then be filtered by Q-score and coverage using the ‘Filter Pileup’ command 
of SAMtools in order to increase the confidence of variant calling (Li et al. 2009).  Data 
outputs are then copied to an Excel Spreadsheet where rudimentary statistics are applied 
to each position.  An example of data outputs are shown in Table 1. 
 
Table 1 – Example data output for donor 005-CF40Buccal (unmixed) using the Galaxy™ pipeline described in Figure 17 and sorted in 
descending order by total number of deviants.  From left to right, the columns are as follows:  CHROM = Reference genome, POS = 
position within reference, REF = reference call at respective position, T#oRs = total number of reads, A/C/G/T calls = individual bases 
called at that position, QARs = quality adjusted reads (number of reads retained after terminal filtering regime), T#oDs = total number 
of deviants (differences from the reference), %MAJ = percentage of basecalls that are the most prevalent basecall, %MIN = 
percentage of basecalls that are the second most prevalent basecalls.  Purines and pyrimidines are shaded in different colors. 
Gold = expected variants for the donor, Yellow  = unexpected minor variant (>1%), Blue = errors in alignment associated with C-
stretch regions, Gray = misaligned reads within the sequence window, Dark blue = an insertion site at the end of a 6 base stretch of 
adenosine residues, Red = nuclear pseudogene (NumtS) that was discovered (Bintz et al. 2012) and now, is expected to cooamplify 
with the HV1b primer set.  Unshaded positions (195 and 204) are positions in which no variant is expected.   
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CHAPTER THREE:  MATERIALS AND METHODS 
Section 3.1:  Sample collection 
 Blood, buccal, and hair samples were collected from twenty donors according to 
the Human Subjects Institutional Review Board policies of Western Carolina University 
following informed consent. 
Section 3.2:  Sanger sequencing of the human mitochondrial HV region from the 
provided blood samples of twenty donors 
 Templates intended for downstream Sanger sequencing were derived from blood 
extracts stored on FTA® cards and were extracted using the Whatman FTA® Protocol 
BD09.  An ‘FTA® disc’ was obtained by punching a hole in the blood stained portions of 
the storage card using the 1.2mm diameter Harris micro puncher and the disc was stored 
in a UV-treated microcentrifuge tube for no longer than a week, until the samples could 
be readied for PCR.  No post extraction quantification was performed.  Non-template 
controls and reagent blanks were prepared alongside samples.  Prepared FTA® discs 
were gently coerced into their respective wells on a 96-well plate using a fresh pipet tip, 
taking care to avoid static charge that might alter the discs’ trajectory.  Amplification of 
the mtDNA hypervariable was performed by including 1.2 mm discs in 20 µl of PCR 
master mix.  The PCR master mix was constructed in the following volumes:  5.00 µl of 
Bovine Serum Albumin (1.6 µg/µl), 2.00 µl of the light strand primer (10 µM), 2.00 of 
the heavy strand primer (10 µM), 2.50 µl of 10X LA PCR Buffer II (Mg
2+
 included), 4.00 
of LA PCR dNTP mix (2.5 mM each), 0.25 µl of Takara LA Taq™ DNA polymerase  
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 HV1a – A1: (L 15997)  5’-CAC CAT TAG CAC CCA AAG CT-3’ 
   B2: (H 16237)  5’-GGC TTT GGA GTT GCA GTT GAT-3’ 
 HV1b –  A2: (L 16159)  5’-TAC TTG ACC ACC TGT AGT AC-3’ 
   B1: (H 16391)  5’-GAG GAT GGT GGT CAA GGG AC-3’  
 HV2a –  C1: (L 048)  5’-CTC ACG GGA GCT CTC CAT GC-3’ 
   D2: (H 285)  5’-GGG GTT TGG TGG AAA TTT TTT G-3’ 
 HV2b –  C2: (L 177)  5’-TTA TTT ATC GCA CCT ACG TTC AAT-3’ 
   D1: (H 409)  5’-CTG TTA AAA GTG CAT ACC GCC-3’ 
Table 2 – Light and heavy strand primers used to amplify the HV sub-regions of the human mtGenome. 
(5U/µl).  Light and heavy strand primer sequences are shown in Table 2.  Thermal 
cycling was performed on Applied Biosystems GeneAmp® PCR System 9700 with the 
following thermal profile:  1 cycle of 95°C for 11 minutes, 32 cycles of 95°C for 10 
seconds, followed by 60°C for 30 seconds, followed by 72°C for 30 seconds, 1 cycle of 
15°C, and cycling ends with a 4°C hold.  Amplicons are cleaned by adding 2 µl of 
ExoSAP to every 5 µl of amplified DNA product.  Cleaned amplicons are quantified on 
the Agilent 2100 Bionanalyzer using P1000 reagent kit.  Derived concentrations are used 
to calculate the dilution needed to obtain 20 ng of amplified product in a 7 µl volume and 
amplified products were diluted accordingly.  Cycle sequencing was performed using half 
reactions of the BigDye v1.1 kit in the following stoichiometric volumes:  4.75 µl of 
diluted BigDye v1.1 sequencing mix, 1.75 µl of sequencing primer (see Table 5), and 
3.50 µl of template DNA (approximately 10 ng).  Dilutions of BigDye v1.1 sequencing 
mix are performed according to the number of reactions being processed in batch.  
Thermal cycling was performed of the Applied Biosystems GeneAmp® PCR System 
9700 with the following thermal profile:  1 cycle of 96°C for 1 minute, 25 cycles of 96°C 
for 15 seconds, followed by 50°C for 1 second, followed by 60°C for 1 minute, and 
cycling ends with a 4°C hold.  Sequenced products were then cleaned using Centri-Sep™ 
96-well spin plates and according to protocol provided by Princeton Separations.  
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Cleaned products are resuspended in 10 µl of Hi-Di Formamide and loaded onto the 
Applied Biosystems® 3130xl Genetic Analyzer for sequencing.  Sequence analysis was 
performed using the fragment analysis on the ABI Data Collection Software and POP-6.  
ABI Prism® Sequencing Analysis Software v5.0 performed basecalling using the KB 
basecaller and visualization of chromatogram data aligned against the rCRS was 
performed using Sequencher v4.8.  Nucleotide differences from the aligned reference 
were recorded for each donor.  After acquiring Sanger data for twenty donors, partner 
pairs were selected based on the maximum number of SNP differences within each of the 
four HV sub-regions.  Analysis of Sanger data indicated 001-CF30 & 005-CF40 and 003-
54M & 015-AM35 to be good candidates for deep sequencing mixture experiments.   
Section 3.3:  Performing the mixture study on the Illumina® MiSeq™ using amplicons 
derived from extracted buccal DNA 
 Extraction was performed on the buccal swabs of specified donors using the 
QIAmp mini spin kit’s Buccal swab spin protocol and according to the volumes specified 
for ‘cotton or DACRON’ swabs.  Extracts were quantified using Applied Biosystems 
Quantifiler™ kit and the ABI 7500 Real Time PCR System according to vendor 
guidelines (Applied Biosystems 2006).  Quantified extracts were diluted to 1 ng/µl 
concentrations of nucDNA to dilute down mtDNA input into PCR reactions.  
Amplification of the HV sub-regions was performed in 25 µl volumes using the indicated 
primer pairs (Table 2) and the Roche® FastStart family of PCR reagents in the following 
stoichiometric volumes:  10.00 µl of template DNA (1 ng/µl nucDNA), 1.00 µl of the 
light strand primer (10 µM), 1.00 µl of the heavy strand primer (10 µM), 2.50 µl of 10X 
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Roche PCR reaction Buffer (with 18mM MgCl2), 0.50 µl Promega dNTP mix (10 mM 
each), and 0.25 µl of Roche FastStart Enzyme (5U/µl).  Thermal cycling was performed 
on Applied Biosystems GeneAmp® PCR System 9700 with the following thermal 
profile:  1 cycle of 95°C for 2 minutes, 32 cycles of 95°C for 30 seconds, followed by 
60°C for 30 seconds, followed by 72°C for 30 seconds, 1 cycle of 72°C for 7 minutes, 
and cycling ends with a 4°C hold.  Amplicons were cleaned by adding ExoSAP in a ratio 
of 2 µl of ExoSAP to every 5 µl of amplified DNA product.  Cleaned amplicons are 
quantified on the Agilent 2100 Bioanalyzer using the P1000 reagent kit and in 
quintuplicate to control for instrument variation.  A quantified average was used to dilute 
down amplicons to a 0.2 ng/µl concentration in a 200 µl volume.  Lower total volumes of 
dilutions were used where appropriate.  From each amplicon dilution, 50 µl was then 
alloquated into a single micocentrifuge tube, representing the HV library of a single 
reference.  Mixtures were then constructed between partners using these reference 
libraries at the 5, 2, 1 and 0.5% of minor contributor.  Reciprocal mixtures between 
donors were also prepared.  From these libraries, 1 ng of input DNA was entered into 
Nextera® XT and given unique sample indices.  A total of 23 samples were prepared 
using Nextera® XT representing:  4 unmixed references, 16 mixture experiments, 1 
positive control (HL60), 1 non-template control, and 1 reagent blank.  An instrument 
control genome, PhiX, was spiked into the pooled amplicon library (PAL) at 8 pM to 
compose 20% of the PAL’s volume.  This deviation from the outlined protocol occurred 
at step 6 during ‘Library Pooling and MiSeq™ Sample Loading.’  This was performed 
out of a concern that Nextera® XT may not fragment small amplicons (<300 bp) at 
enough locations to properly balance the run and represents the only deviation protocol.  
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The PAL was then diluted to 1/25
th
 of its concentration in accordance to the protocol’s 
specifications and loaded onto the sequence cartridge.  The sequence cartridge was then 
loaded onto the Illumina® MiSeq™ and the following addendums were made to the 
Sample Sheet:  ‘VariantCaller = somatic; VariantFrequencyFilterCutoff = 0.001.’  The 
library was then sequenced in a 2x150, paired-end run.  Resulting .fastq files were 
analyzed using the developed Galaxy™ bioinformatics pipeline. 
Section 3.4:  Performing the mixture study on the Illumina® MiSeq™ using amplicons 
derived from extracted blood DNA 
 For specified donors, DNA derived from blood samples stored on FTA® cards 
were extracted using the Whatman FTA Protocol BD09.  No post extraction 
quantification was performed.  Discs were transported to respective wells on at 96-well 
plate and amplification of the HV sub-regions was performed in 25 µl volumes using the 
indicated primer pairs (Table 2) and the Roche® FastStart family of PCR reagents in the 
stoichiometric volumes presented in the buccal mixture experiment.  These amplicons 
were amplified, cleaned, quantified in quintuplicate, normalized, pooled, mixed, and 
taken through Nextera® XT as indicated in the previous section, creating a total of 23 
prepared samples representing:  4 unmixed references, 16 mixture experiments, 1 positive 
control (HL60), 1 non-template control, and 1 reagent blank.  PhiX, was spiked into the 
PAL at step 6 of ‘Library Pooling and MiSeq™ Sample Loading’ and at 8 pM to 
compose 20% of the PAL’s volume.  The PAL was then diluted to 1/50
th
 of its 
concentration, a deviation that is recommended by Illumina® if previous runs are 
observed to over cluster (which occurred).  The diluted PAL was processed for 
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sequencing as described earlier and resultant .fastq files were analyzed using the 
Galaxy™ bioinformatics pipeline. 
Section 3.5:  Performing the tissue study on the Illumina® MiSeq™ using amplicons 
derived from hair DNA 
 Stereoscopic inspection of hair samples from specified donors observed the root-
end of each hair.  An inch from the root-end of the hair was removed and the next 2 cm 
of hair shaft was used for mtDNA extraction.  Templates were derived from five different 
hair shafts from each donor and were extracted using the hybrid Qiagen digestion/ABI® 
PrepFiler™ purification methodology (Burnside et al. 2013).  Quantification of hair 
extracts was performed using the mitochondrial DNA quantification assay described by 
Kavlick et al. (2011).  Concentrations of hair DNA were diluted to 1750 copies/µl in 
order to input 17500 copies of mtDNA into each amplification reaction.  Amplification of 
the HV sub-regions was performed in 25 µl volumes using the indicated primer pairs 
(Table 2) and the Roche® FastStart family of PCR reagents in the stoichiometric 
volumes presented in the buccal mixture experiment.  Hair derived amplicons were 
amplified with the same thermal profile indicated in the previous sections with the 
exception of 36 cycles instead of 32.  Amplicons derived from hair were purified, 
quantified, normalized, pooled, and taken through Nextera® XT as previously described, 
creating a total of 23 prepared samples representing 19 or 21 samples (depending on the 
number of hairs successfully amplified) representing:  2 buccal samples, 1 buccal non-
template control, 1 buccal reagent blank, 1 buccal positive control (HL60), 8 or 10 hair 
samples, 2 hair non-template controls, 2 hair reagent blanks, and 2 hair positive controls 
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(HL60).  PhiX was spiked in at 20% and the diluted PAL (1/50
th
) was processed for 
sequencing as described earlier.  Resultant .fastq files were analyzed using the Galaxy™ 
bioinformatics pipeline.  
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CHAPTER FOUR:  RESULTS 
Section 4.1:  Cycle sequencing of the HV sub-regions twenty donors and assigning two-
person mixtures 
 Using Sequencher v4.8, chromatogram data was aligned against the rCRS.  Bases 
receiving poor base quality were trimmed from aligned data and descriptive SNPs were 
recorded.  SNP positions were only recorded if the sequenced amplicon had at least 
double coverage (either from forward and reverse reads or overlapping coverage from the 
neighboring amplicon) over the SNP position.  Amplicons whose sequence data were of 
poor quality were rerun on the Applied Biosystems® 3130xl Genetic Analyzer.  
Amplicons whose sequence data were uninterpretable were resequenced, purified, and 
run on the capillary electrophoresis instrument.  Analysis of the chromatograms derived 
from the blood samples of twenty donors are displayed in Tables 6 and 7.  An inspection 
 
Table 3 – Cycle sequencing data for the descriptive SNPs found in HV1a and HV1b of the twenty donors.  Underlined SNPs fall 
within a primer binding site.  Bold SNPs are transversions.  Donors earmarked with an “!” showed length variants in the HV1 C-
stretch.  Donors earmarked with an “*” showed length variants in the HV2 C-stretch.  
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Table 4 – Cycle sequencing data for the descriptive SNPs found in HV2a and HV2b of the twenty donors.  Underlined SNPs fall 
within a primer binding site.  Bold SNPs are transversions.  Donors earmarked with an “!” showed length variants in the HV1 C-
stretch.  Donors earmarked with an “*” showed length variants in the HV2 C-stretch.  
of the SNP data revealed that donors 001-CF30 & 005-CF40 to be good candidates for 
deep-sequencing mixture experiments, as well as 003-54M & 015-AM30, based on the 
respective frequency of identifying SNPs that occurred in each HV sub-region. 
 
Table 5 – SNP differences across the four HV amplicons for donors 001-CF30, 005-CF40, 003-54M, and 015-AM35.  
Section 4.2:  Summary of the mixture study from buccal samples 
 Buccal swab extracts were quantified using the Quantifiler™ Kit according to 
vendor specifications (Applied Biosystems 2006).  Concentrations of nucDNA were in  
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Table 6 – Post extraction quantification of buccal extracts using Quantifiler™ and averaged post-amplification quantification using the 
Agilent 2100 Bioanalyzer for amplicons derived from buccal tissue. 
terms of ng/2µl.  After quantification, extracts were diluted down to 1 ng of nucDNA per 
µl in order to dilute down the mitochondrial copy number of the extracts, which were 
expected to saturate the extract.  This is common practice in forensic estimations of 
mtDNA inputs.  After PCR, the sample and positive control amplicons were quantified in 
quintuplicate to reduce the effect of instrument variation on DNA inputs into Nextera® 
XT.  The negative controls were quantified once.  Results are shown below. 
 MiSeq™ run quality metrics and the number of clusters per index were 
determined using MSR v2.0.  A summary of the run quality metrics and a total of the 
number of clusters that had usable data are shown in Table 7.  Other run quality metrics 
(not shown) indicated that over clustering did occur and that cluster density achieved  
 
Table 7 – Run quality metrics for the buccal mixture study.  Raw = raw number of clusters recorded by the instrument, PF = number 
of clusters which passed the instruments chastity filter for confident base calling, Unaligned = number of clusters which pass filter but 
did not align to the reference, Unindexed = number of clusters which pass filter but have no indices, Phasing 1 & 2 = percentage of 
clusters in the forward (1) and reverse (2) sequence reads that fail to incorporate a dNTP, Prephasing 1 & 2 = percentage of clusters 
that incorporate more than one dNTP, MisMatch 1 & 2 = percentage of base mismatches to reference averaged over all cycles, Align 1 
& 2 = percentage of clusters that align to the rCRS, PE Resynth = percentage of clusters that successfully recorded both forward and 
reverse sequence data. 
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approximately 1,100 K clusters/mm
2
.  The ideal maximum range for cluster density on 
the Illumina® MiSeq™ is 850 K clusters/mm
2
.  Over clustering notwithstanding, the run 
still achieved a high percentage of reads that passed filter (83.4%) with nominal rates of 
phasing (0.186%, 0.218%) and prephasing (0.182%, 0.187%).  Phasing is the rate in 
which clusters fail to incorporate the next dNTP in the sequence, and thus, the derived 
sequence information lags behind by one base.  Prephasing is the opposite and occurs 
when a cluster incorporates more than one dNTP.  Future sequencing runs increased the 
dilution factor of the PAL during Nextera® XT to compensate for over clustering.  
Higher rates of base mismatches averaged over all cycles (1.306%, 1.343%) and the low 
average number of reads which align to the rCRS (76.1%, 74.7%) are intriguing.  Paired-
end resynthesis was successful and there were few duplicate clusters (clusters that share 
sequence basecalls and have the same start/ending positions).  Raw .fastq outputs were 
obtained from the instrument and analyzed using the bioinformatics pipeline detailed in 
Figure 17.  A summary of the run’s analyzed data is presented in Appendix 1.   
Section 4.3:  Summary of the mixture study from blood samples 
 After PCR, amplicons derived from the blood of the four donors and positive 
control amplicons were quantified in quintuplicate.  The negative controls were 
quantified once.  Results are shown in Table 8.  The dilution step during Nextera® XT 
was adjusted to comprise a 50 fold dilution of the PAL.  Derived quality metrics 
indicated that the blood mixture study achieved a cluster density of approximately 1,126 
K clusters/mm
2
 which did not seem to greatly impact the percentage of reads that passed 
filter (84.4%, Table 9). After sequencing, raw .fastq outputs were obtained from the 
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Table 8 – Averaged post-amplification quantification for amplicons derived from blood tissue using the Agilent 2100 Bioanalyzer. 
 
Table 9 – Run quality metrics for the blood mixture study.  See Table 7 for interpretation guidelines. 
instrument and analyzed using the bioinformatics pipeline detailed in Figure 17.  A 
summary of the run’s analyzed data is presented in Appendix 2.   
Section 4.4:  Summary of sequencing results from hair shaft samples 
 Hair extracts that passed qPCR results were chosen for deep sequencing.  Hair 
extracts that entered downstream PCR had to have at least 1,000 copies of mtDNA per µl, 
show no evidence of inhibition, and be at least 10 times greater in concentration than its 
corresponding reagent blank.  qPCR of hair extracts consistently resulted in a standard 
curve that fell outside the recommended range (-3.38 + 0.06) of the publication from 
which the assay was based.  The slope of these standard curves ranged from -3.675 to -
4.081 and may indicate a lower starting concentration of the secondary stock from which 
the standard dilution series was performed.  Effectively, this would lead to an over- 
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Table 10 – Amplification quantification for amplicons derived from hair extracts using the Agilent 2100 Bioanalyzer.  Quantification 
results are divided by the flow cells in which the amplicons would be sequenced.  (Above) Amplicons sequenced during TS1.  
(Below) Amplicons sequenced during TS2.  Hair extracts from donors 005-CF40 and 015-AM35 were amplified on the same PCR 
plate and therefore the same NC-H2O and PC-HL60 controls. 
estimation of quantified DNA product and therefore, the dilution of extracts prior to PCR 
underestimated total DNA input.  This was deemed acceptable considering that the 
purpose of qPCR was to verify sufficient copy numbers within extracts and to screen for 
inhibition.  After PCR, amplicons derived from hair extracts of the four donors, along 
with positive negative controls were quantified once (Tables 10).  The deep sequencing  
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Table 11 – Run quality metrics for the hair tissue studies.  (Left) Quality metrics for TS1.  (Right) Quality metrics for TS2.  See Table 
7 for interpretation guidelines. 
of hair samples derived from the four donors was divided across two different flow cells.  
Donor 001-CF30 and 003-54M and all corresponding samples were prepared on one flow 
cell (TS1), donors 005-CF40 and 015-AM35 were prepared on another (TS2).  Both flow 
cells had additional mtDNAs that were included in the PAL but are not germane to this 
project.  Presented quality metrics (Table 11) include these additional samples in their 
calculations.  The 50 fold dilution of the PAL was maintained across both TS1 and TS2 
and achieved 625 K clusters/mm
2
 and 1,385 K clusters/mm
2
 respectively.  Raw .fastq 
outputs were obtained from the instrument and analyzed using the bioinformatics pipeline 
detailed in Figure 17.  A summary of both runs’ analyzed data are presented in 
Appendices 3 and 4.   
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CHAPTER FIVE:  CONCLUSIONS 
Section 5.1:  Overview of the mixture experiments and minor variant detection 
 An analysis of the results derived from the mixture experiments conclusively 
demonstrate that minor variants can be detected in mixtures of human mtDNA at the 
stated levels of detection using the Illumina® MiSeq™ and the developed bioinformatics 
pipeline.  Tables 12 and 13 are Galaxy™ datasets produced from the mixture study using 
blood as reference material and illustrate this observation in detail.  The implications and 
caveats of this detection method are numerous.  Firstly, this method of data sorting  
 
 
Table 12 – The first 15 entries of data outputs for donors 001-CF30BLD (A) and 005-CF40BLD (I) using the Galaxy™ pipeline 
described in Figure 17 and sorted in descending order by total number of deviants.  Expected variant 16390A was not recovered in 
donor 001-CF30BLD.  Datasets have not been filtered of NumtS variants (red).   
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Figure 18 – A potential method of performing SNP and mixture detection in Galaxy™ outputs.  The minimum post filtered coverage 
(500) for analysis and the interpretation threshold for DNA mixtures (1%) seen here are arbitrarily selected values. 
implies that sequence interpretation can be performed using a series of computational 
‘If/Then' logic statements, like the one shown in Figure 18.  These computations could 
calculate proportions of deviant basecalls, or basecalls that are in disagreement with the 
reference, with respect to the position in which they occur in post filtered sequence reads 
(QARs).  An analysis of these proportions may yield one of three interpretations:  (1) the 
position in question either contains a SNP, (2) the position in question falls below the 
threshold of mixture interpretation and therefore, agrees with the reference, or (3) the 
position in question is falls above the threshold of mixture interpretation and therefore, 
should be considered a site of base mixture.  This method of data analysis would 
however, depend on two user defined variables:  a minimum number of post-filtered 
sequence reads and a yet-to-be described interpretational threshold for interpreting mixed 
positions.  In lieu of justified values, Galaxy™ outputs of MiSeq™ data were instead, 
visually characterized against the Sanger data presented in Table 5 and a color scheme 
was devised to demonstrate the recovery of expected variants and various NGS-related 
artifacts.  An example of a visually characterized dataset is shown in Table 13. 
 Sites of expected variation (EV) based on the prepared mixtures are recovered by 
sorting datasets by %MIN in descending order.  In Table 13, Gold represents an EV of  
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Table 13 – The first 15 entries of data outputs for donors 001-CF30BLD and 005-CF40BLD in the blood mixture experiments, sorted 
by %MIN in descending order.  (Top left) Donor 005-CF40BLD constitutes 5% of the library.  (Bottom left) Donor 005-CF40BLD 
constitutes 2% of the library.  (Top right) Donor 005-CF40BLD constitutes 1% of the library.  (Bottom right) Donor 005-CF40BLD 
constitutes 0.5% of the library.  Expected variant 16390A was not recovered in these samples. 
the major contributor; green, an EV of the minor contributor.  While these experiments 
show that variant positions are detectable at the four levels of resolution, sorting by 
%MIN also recovers several sites of unexpected variation (UV).  Positions which showed 
either a high degree of variation within an unmixed donor or were consistently present in 
mixtures of a specific major contributor were highlighted in yellow, as these sites may 
reflect true biological variation within the donor and may bias averages of %MIN for 
UVs.  Blue positions are areas within or are in close proximity to homopolymeric 
stretches of cytosine residues.  In this instance, both donors have the same C-stretch 
polymorphisms (309.1C, 315.1C) and show no evidence of length heteroplasmy in  
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Figure 19 – Visualization of MiSeq™ derived SAM file using the Broad Integrative Genomics Viewer (IGV).  Only variant sequences 
are reported.  The highlighted sequence shows NumtS variants 16218T, 16230G, and 16249C.   
Sanger data.  While the variants that appear in Galaxy™ datasets may be real length 
variants, the frequencies of %MIN that occur at 302 and 310 reflect an inability of the 
analysis pipeline to align insertion variants in the format adopted for use in forensic 
science.  Red positions are sites associated with nuclear pseudogenes (NumtS) and cannot 
be ruled out as a possible cause of variation.  NumtS are ancient mitochondrial insertions 
into the nuclear genome and have been highly conserved through time (Zischler et al. 
1995).  In separate mixture experiments performed on the Roche® GS Junior, a 
consistent set of variants occurred at specific positions within aligned reads.  A 
subsequent BLASTn search of the deviant sequence revealed them to be of NumtS origin 
and was later confirmed by Sanger sequencing (Bintz et al. 2013).   Since the NumtS 
contains the primer binding sites for primers A2 and B1, NumtS are expected to 
coamplify with the HV1b primer set and have also been identified in the mixture 
experiments performed on the MiSeq™ (Figure 19).  Dark red positions reflect BWA 
alignment errors, two examples of which are demonstrated in Figure 20.  The positions 
presented in Table 13 (558, 568, 572, 573) are associated with a read which has aligned 
to the reference outside the PCR primer binding regions and are not likely to have been 
sequenced given the amplicon design of the project.  Other alignment errors have been 
observed to occur within regions of properly aligned data and have artificially inflated 
calculations of %MIN at affected positions.  A BLASTn search (Table 14) of the five  
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Figure 20 – Visualization of alignment errors due to BWA ‘soft-clipping’ using IGV.  Within the red boxes are short reads that have 
numerous mutations.  These are the reads that have aligned in err.   (Left) Soft-clipped reads fall outside the sequence window and are 
less problematic.  (Right) Soft-clipped reads are within the sequence window, skewing calculations of %MIN. 
 
Table 14 – Misaligned sequences in 001-CF30BLD.  Red bases are sites interpreted as mutations.  Dashes are interpreted as base 
deletions.  Underlined bases are interpreted as base insertions.  “R” are reverse complementary to the indicated sequence.  The 
sequence demarcated with an asterisk is unique to donor 001-CF30BLD, likely due to the fact that this individual as a personal SNP at 
position 16390. 
most prevalent misaligned sequences within 001-CF30BLD using the deviant sequence 
and ignoring deletion sites, revealed these sequences to be identical to other sites within 
the human mtGenome, specifically, at sites expected to have been sequenced given the 
amplicon design of this project.  Discussions with bioinformaticists at Illumina® 
indicated ‘soft-clipping’ had occurred, a secondary alignment process inherent to BWA’s 
paired-end alignment designed to recover poorly aligned reads, and was responsible for 
these errors.  The cause of soft-clipping is discussed in section 5.2. 
 Sites with UVs that could be linked to different NumtS or soft-clipping were 
filtered from mixture datasets to produce Appendices 1 and 2.  C-stretch variants were 
retained for the purposes of calculating the average coverage per base in both pre- and  
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Table 15 – Calculations of average %MIN and standard deviation for expected variants (EVs).  EVs that showed unusually high minor 
variation in unmixed donors were not used to calculate the average %MIN and the associated standard deviation in mixtures where 
that donor was the major contributor.  These values of %MIN differ from those presented in Appendices 1 and 2 which include all 
sites of expected variation. 
post-filtered reads as well as the length of sequence window.  The sequence window is 
the number of positions which retained aligned data.  C-stretch variants were not 
however, considered as sites of expected variation due to the inability of data pileups to 
format insertion sites correctly.  Analysis of filtered datasets showed that a majority of 
EVs could be recovered in mixed and unmixed samples with few exceptions.  
Calculations of %MIN at sites of expected variation, using only the EVs that did not 
show unexpectedly high levels of variation in unmixed donors (Table 15), clustered these 
values around the expected levels of detection.  An unweighted average (ignoring 
coverage) of these values corroborated this.  Calculated standard deviations from these 
averages show that a relatively wide range of variation (~0.5%) among EVs can be 
achieved.  These calculations however, should be taken with a degree of skepticism given 
the limitations of the bioinformatics pipeline, which is discussed in section 5.2.  
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Additionally, when data tables for lower levels of resolution (0.5-1%) are sorted by 
%MIN, the number of UVs recovered, or positions that show higher values of %MIN 
than sites of expected variation, increases.  The recovery of UVs at lower levels of 
resolution are depicted in Appendices 1 and 2. 
 One EV in particular, 16390A in donor 001-CF30BLD, consistently dropped out 
in each associated mixture.  This occurred in samples that achieved the largest number of 
positions sequenced (722 bp), the highest raw clusters PF (441 K), and in samples that 
achieved the highest average coverage per base (5133.60) following bioinformatic 
filtering.  This indicates that these calculations may not be the most relevant data in the 
recovery of all EVs.  Indeed, the proximity of this variant to the distal end of the HV1b 
amplicon (primer B1 primer binds to positions 16391-16410) is concerning since a 
technical note provided by the vender warns of an appreciable drop in coverage 50 bases 
in from each end of the amplicon (Illumina® 2012b).  This drop in coverage is attributed 
to the inability of the transposons to correctly incorporate a second PCR primer site after 
fragmenting an amplicon near its distal end and is demonstrated in Figure 21 for greater 
clarity.  Should fragments containing only ‘A’ or ‘B’ primer binding sites make it into the 
PAL, the fragments will not be able to perform bridge amplification.  Increasing the size 
of the amplicons to be sequenced may recover these distal variants, but encumbers the 
successful amplification of mtDNA from the most challenging sample types—highly 
fragmented DNAs are amplified better with smaller designs.  A more effective solution 
may be to incorporate the primer binding sequences used during Nextera® XT’s short-
interval PCR onto the 5’-ends of the HV primer sets.  The result is illustrated in Figure 
22.  Of consequence, SPRI bead clean-up will recover shorter fragment sizes that are 
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Figure 21 – Illustration of how Nextera® XT prepares template molecules for sequencing (Illumina® 2012b).  The ‘tagmentation’ 
process results in fragments that either have the ‘A’ primer site, the ‘B’ primer site, or both ‘A’ and ‘B’ primer sites.   
 
Figure 22 – The same illustration but with templates prepared using modified primers that incorporate the Nextera® XT PCR primer 
binding regions (Illumina® 2012b).  Every product of the ‘tagmentation’ process should have both ‘A’ and ‘B’ primer sites.   
capable of downstream bridge amplification and will likely compete for space on the 
flow cell.  This may potentially decrease the overall yield of a sequencing run using the 
current method of sample preparation. 
Section 5.2:  Limitations of the Galaxy™ pipeline 
 Many bioinformatic algorithms are coded in Linux command prompt and many 
software packages (NextGENe®, CLC Bio) are marketed for expressed purpose of 
simplifying bioinformatics through tool-based GUIs.  However, without a complete 
understanding of the Linux command prompt and the effects of toggling tool parameters, 
the user is limited by the capabilities of preselected features.  In these experiments, BWA 
paired-end alignment was utilized for three reasons:  (1) it had a published error rate, (2) 
it was one of two alignment tools Galaxy™ offered for Illumina® data, and (3) the 
service itself was free.   
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 While Galaxy™ does allow the user to modify many parameters of BWA paired-
end alignment, it does not currently allow the user to toggle-off ‘soft-clipping.’  When 
aligning paired-end data, BWA will perform Smith-Waterman alignment on unaligned 
sequences in an attempt to recover reads that have not mapped confidently by aligning 
the sequence to suboptimal hits (Li & Durbin 2009).  This will occasionally clip and 
discard large portions of sequence reads, from anywhere between 100-130 bases, if the 
retained sequence has a higher mapping quality than the complete string.  This may 
explain why when soft-clipping is suspected, it generally occurs in both a smaller 
proportion of reads as well as in a single direction—mapping quality for the one mate 
pair is calculated independently of the other, allowing one to map perfectly while the 
other does not.  Of particular concern is the occurrence of unique soft-clips.  The 
sequence demarcated by the asterisk in Table 14 is a misaligned sequence that does not 
occur in any other donor and should have aligned to 16372-16395.  This misaligned 
sequence contains the 16390A EV of donor 001-CF30 and is alarming considering that a 
single SNP difference lowered the mapping quality enough to cause the aligner to 
misplace associated reads to a sub-optimal hit.  Combined with low coverage, this may 
explain why the 16390A EV is not recovered in every experiment containing this donor.  
Misalignment due to poor mapping quality can be particularly problematic, especially for 
donors like 002-CM32.  While samples from this donor were not deep sequenced in these 
experiments, this donor has three SNPs that are less than nine bases apart (199C, 204C, 
207A).  It stands to reason that the more SNPs a donor has within a sequence read, the 
greater the likelihood it will map erroneously using this method of analysis. 
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 Soft-clipping is a systemic error and while it easy to visually locate misaligned 
sequences in small amplicon projects, projects that intend to sequence the entirety of the 
mtGenome will have difficulty isolating soft-clip induced noise if it does not disable this 
feature.  Again, for the Linux savvy, this feature can be disabled in BWA command 
prompt by toggling “- s” so that it does not perform Smith-Waterman alignment on sub-
optimal hits.  This will make no attempt to recover unconfidently mapped reads.  
Alternatively, one could search the CIGAR strings of produced SAM files and filter all 
aligned reads containing “S” (S = soft-clip) and then, reupload the SAM file for further 
analysis.  This alternative does represent a considerable time and technological 
investment, as one will likely need a computer capable of opening an Excel file with, on 
average, 70,000+ lines of text (each line representing an individual aligned read).  This 
was not performed on produced datasets and instead, positions that were known to 
succumb to misaligned data were visually filtered from further analyses. 
 In Galaxy™, the ‘Generate pileup’ function of SAMtools has an approximate 
computational 8,000 line read cap over aligned positions and introduces bias into relevant 
calculations, such as the average coverage per base calculation shown in all attached 
appendices.  This computational cap was set by the service provider to keep positions that 
have a phenomenal depth of coverage from chewing up too much bandwidth.  
Additionally, comparisons of multiple pileups generated from a single SAM file (data not 
shown) revealed that selected reads appear to be non-randomly selected.  The tool may 
likely be selecting the first 8,000 reads that have aligned over a particular position and is 
an additional source of bias, but is not nearly as limiting as the cap itself. 
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Section 5.3:  Reagent blank and negative control contamination 
 Reagent blanks (RBs) and PCR negative controls in experiments involving the 
use of buccal reference material produced a significant amount of NGS data (Appendices 
1, 3, and 4).  This is alarming considering that at no point during the sample preparation 
was contamination suspected.  The Quantifiler™ qPCR assay used to quantify the 
nucDNA concentration of buccal extracts returned a negative result for the RBs that were 
prepared alongside reference material from donors 001-CF30, 003-54M, and 005-CF40.  
Unlike samples extracts, these RBs remained undiluted after post extraction 
quantification of nucDNA content.  On two different dates, 10 µl of the prepared RB 
(RB-Buc-1, 3, 5) was input into the four respective PCR reactions, targeting the human 
CR—one reaction performed on one day was for the buccal mixture experiment, the other 
reaction was for the buccal reference in the tissue study experiment.  Aside from the date 
in which these reactions were performed, nothing differed between PCR reactions.  Post 
amplification quantification using a P1000 kit on the Agilent 2100 Bioanalyzer revealed 
that sample controls achieved a negative result (Table 6).  It was not deemed necessary to 
quantify negative controls more than once.  When samples were normalized to 0.2ng/µl 
concentrations and input into Nextera® XT, 5 µl of the undiluted RB was input into its 
respective reaction tube.  When sample preparation was completed, pooled libraries were 
deep sequenced on the Illumina® MiSeq™.  An analysis of the unexpected variants that 
appeared within the RB-Buc-1, 3, 5, linked several SNPs to donors that were prepared 
during a batch extraction.  Specifically, these SNPs could be associated with references 
002-CM32, 006-CM25, 019-UF24, and 020-AF44.  At no point during the mixture 
experiments did reference material from these donors share hood-space with the prepared 
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reagent blank except during extraction, when references 001-006 and 017-020 were 
prepared in batch.  Therefore, contamination could only have occurred during extraction 
and failed to achieve a positive result at multiple downstream quality control checks.  In 
one instance, an RB that passed on the Agilent 2100 P1000 kit yielded upwards of 273 K 
clusters (Appendix 4). 
 At no point during the course of these experiments was the RB diluted at a 
proportion equivalent to what the samples experienced.  Buccal references were diluted at 
two different intervals.  Specifically, these samples were diluted after post-extraction 
quantification and after post-amplification quantification, resulting in ~5 and ~100 fold 
dilution factors, respectively.  If reference material was contaminated at extraction, this 
contamination would likely represent a small proportion of that reference library and 
would also be diluted at the same proportions the library experienced.  This may explain 
why SNPs observed in RB-Buc-1, 3, 5 cannot be identified in any of the NGS datasets 
that used buccal reference material (Appendices 1, 3, 4).  Since the RBs remained 
undiluted, the samples used to produce these datasets did not experience the same 
conditions in which reference material was treated.  Therefore, conclusions drawn from 
these RBs may not accurately portray the degree in which contamination could have 
occurred.  Interestingly, and perhaps one of the greatest strengths of deep-sequencers, is 
that if contamination is suspected in NGS data, the user has the ability to look deep 
within sequence reads (provided the computational cap of data pileups has been removed) 
and to discern the degree in which the contamination is present. 
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 Given the highly sensitive nature of mtDNA, contamination of the RBs is not 
entirely unexpected and interpretational guidelines for casework compensate for this (RB 
copy number cannot exceed 10% of the sample concentration following qPCR).  
However, mtDNA has not been previously scrutinized at this level of resolution.  Indeed, 
the Agilent 2100 Bioanalyzer P1000 kit has a quantitative range of 0.1 ng/µl and 
normalizing experiment samples to 0.2 ng/µl prior to Nextera® XT dilutes sample inputs 
to concentrations twice the instrument’s limit of detection (LOD).  This may explain why 
RB-Buc-1, 3, 5 achieves a raw cluster count that is comparable to experimental samples.  
Agilent does produce high sensitivity kits (LOD = 5-500 pg/µl) which may warrant 
further investigation.  However, the lack of contamination in RBs derived from blood and 
hair extracts points to the efficacy of the buccal extraction procedure.  When NGS data 
for RB-Buc-1, 3, 5 is compared against RBs prepared using alternative extraction 
procedures (FTA® cards for blood, hybrid Qiagen digestion/Prepfiler™ BTA 
purification for hair), these alternative extraction procedures either yield no reads or 
uninformative reads when taken through the bioinformatics pipeline (Appendices 2, 3, 
and 4).  Perhaps Qiagen’s buccal swab spin protocol for samples intended for deep-
sequencing is less than optimal, considering the high concentration of mtDNA per swab 
and the multiple high-volume sample transfer steps.  Remarkably, the RBs for the blood 
samples, even when undiluted after post-amplification quantification, produced less than 
500 clusters from which to derive sequence data.  This method of extract merits further 
investigation for samples intended for deep-sequencing. 
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Section 5.4:  Assessments of noise and designing experimental controls 
 An experimental goal was to reliably detect minor variants above some 
measurable level of noise.  Identifying patterns of noise is important, as accounting for its 
sources will likely affect relevant calculations of LOD.  It was assumed that unexpected 
variation was noise.  This noise is observed at low levels and appears mostly as transition 
differences (Table 16).  There are many possible explanations for this:  (1) the minor 
variation represents an instrument error, (2) the noise is PCR induced substitution, (3) the 
noise represents true heteroplasmy at extremely low levels, or (4) some combination 
thereof.  A reexamination of how the instrument performed sequence analysis eliminated 
instrument error as a potential cause of variation.  One of the major improvements that 
the MiSeq™ made over previous generations of Illumina® instruments is that it now 
excites fluorophores with a green and red LED.  The red LED excites fluorophores for 
adenosine and cytosine; the green LED for guanine and thymine.  This creates a filter and 
effectively separates the excitation of purines and pyrimidines.   
 
Table 16 – The first twenty entries of Galaxy™ data for 5% Donor 001-CF30BLD::95% Donor 005-CF40BLD mixture experiment.  
Sites of unexpected variation have their minor basecalls boxed and appear as transitions. 
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 It may be possible to statistically assess noise within Galaxy™ outputs.  Early 
attempts to assess noise performed Monte Carlo sampling on confusion matrices that 
were generated from alignments of the PhiX control.  This confusion matrix uses an 
aligned reference to tabulate the number of associated basecalls when a particular base is 
expected.  An example of this is given in Table 17 and states that from all the 
independently aligned reads, 216 “C” calls were made when “A” was expected to be true.  
From this confusion matrix, an expected frequency matrix could be constructed.  PhiX 
was spiked in to each of the experiments to constitute 20% of the library by volume.  This 
was done initially out of a concern that the random fragmentation of small amplicons 
during Nextera® XT would create a library with low diversity.  While this was not the 
case, PhiX sequence information could however be used to provide an instrument 
control—it is a synthetic piece of DNA that could hybridize to the flow cell and bridge 
amplify but is not amplified either during Nextera® XT processing or prior to it.  
Unindexed reads in run quality metrics (Tables 7, 9, 11) were the PhiX reads and their 
resultant sequence information was parsed by the instrument into an ‘Undetermined’  
 
Table 17 – Confusion matrices (top left), expected frequencies (top right), and simulated χ2 values using Monte Carlo sampling of the 
PhiX control DNA (bottom).  χ2 values were simulated at 100x increments (coverage) up to 8,000 trials (not all simulations shown). 
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Table 18 – Application of the Monte Carlo method to Galaxy™ outputs for 001-CF30Buc unmixed where the null hypothesis does not 
rule out instrument error for the distribution of observed bases.  All sites that where estimated pass = ‘True,’ reject the null 
hypothesis—that something other than instrument error resulted in the observed base distribution.  The simulated χ2 value used at each 
position was fitted to along the χ2 plot in Table 16 using coverage and reference call. 
fastq. file.  ‘Undetermined’ fastq. files were taken from the instrument and aligned to the 
PhiX genome using the same filtering criteria described above.  All ambiguous bases 
(‘N’) were then trimmed from aligned reads and a confusion matrix (Table 17, top left) 
was constructed by examining all the aligned sequence reads and totaling the number of 
basecalls when a particular base was expected.  This gives a distribution frequency of 
correctly called and miscalled bases (Table 17, top right).  Monte Carlo sampling was 
performed to compare observed χ
2
 values against simulated χ
2
 values that were obtained 
through computational trials using the distribution frequencies for PhiX (Table 18).  This 
method of analysis was suggested given the low expected values observed in Table 18 
(Jocelyne Bruand, Illumina®, personal communication).  Using the obtained distribution 
frequencies, Monte Carlo sampling was performed over a number of trails that 
incrementally increased by 100X coverage until it achieved 8,000 trials.  Obtained χ
2
 
values were not demonstrably different from those obtained using 50,000 and 100,000 
trials.  When the calculated p-value for a particular position fell below an alpha-value of 
0.01 and the calculated χ
2
 was greater than its simulated value, then a value of ‘TRUE’ 
was given.  This is interpreted as a rejection of the null hypothesis, that the test could not 
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eliminate instrument error (based on the PhiX distribution) as a potential explanation for 
the observed basecalls.  When the null hypothesis is rejected at a p-value of 0.01, 
instrument error alone cannot explain the observed distribution of basecalls. 
 These statistical analyses were performed well before it was deduced that 
instrument error was likely not a factor in generating these calls.  However, it does offer a 
methodology for analyzing future controls which may explain the predominance of 
transitions.  PhiX is a synthetic genome and may not exhibit the same pattern of 
substitution observed in mtDNA.   The positive control, HL60, comes from an 
immortalized, cancer cell-line and shows high variation at several positions across 
independent sequencing runs—runs which used amplified mtDNAs from separate PCR 
reactions that were performed under similar conditions.  Far more desirable as a control 
would be a singular mtDNA haplotype.  Methods of subcloning DNA isolated a single 
mtDNA haplotype in experiments intended for Sanger sequencing (Pfeiffer et al. 2003) 
but may still exhibit a low rate of substitution induced by the enzymatic amplification of 
DNA during processing and could alter the observed basecall distribution in NGS 
datasets.  An alternative may be to synthetically prepare DNA fragments.  These 
fragments would have a similar base composition to mtDNA.  Additionally, the sum of 
these synthetic fragments could cover the entirety of the mtGenome.  Whether developed 
in-house or commercially purchased, a control mtDNA that is properly balanced and 
capable of bridge amplification may be useful for measuring the rates of PCR induced 
substitution.  If the deep-sequence results from an unamplified control DNA has a 
substantially different background pattern compared to an amplified counterpart, then it 
could be said that the observed background may be the result of PCR induced 
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substitution.  If not, then the observed background in these experiments may be attributed 
to biological variation. 
Section 5.5:  Suggestions for establishing an interpretational threshold and optimizing 
depth of coverage 
 It is difficult to establish an interpretation threshold beyond an arbitrary value of 
1% without accounting for all relevant NGS variables.  Many variables are present which 
may affect assessments of observed noise.  For example, there are many methods of data 
filtering based on quality metrics.  The quality filtering scheme applied by this project 
(>Q20 over 90% of the base composition) was performed in order to prevent alignment 
of poorer quality sequences from competing with better quality reads for space in the 
capped data pileups.  The removal of the computational cap from data pileups may merit 
an investigation of other methods of quality filtering and their respective effects on the 
sequence data.  Also, filtering criteria may have some platform specific components to it.  
For example, Illumina® data tends to be of poorer quality closer to the 3’-end of the 
sequence read, which may require some trimming in order to generate reads with higher 
mapping quality. 
 Different alignment algorithms perform in different ways.  For instance, the local 
alignment tool in CLC bio clips sequence entries into small fragments of approximately 
20 bases in length and will remove poor quality basecalls from generated fragments.  The 
software will then attempt to align each fragment to the reference using mismatch and 
gap penalties defined by the user.  As penalties accrue, the software has less confidence 
in the alignment and will then seek to align the fragment elsewhere until an alignment 
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with the highest mapping quality is reached.  This method of alignment is generally better 
at describing insertion sites around homopolymeric stretches than the analysis pipeline 
described in this project.  However, it is not known how the local alignment algorithm 
may perform when several SNPs are in close proximity, and also, how reads that are 
NumtS in origin are handled. 
 Sequencing the primer is of no biological relevance and because of this, primer 
sequences are usually trimmed from NGS datasets.  Primer trimming can be a challenge 
if overlapping amplicons constitute the DNA library.  For example, a trimming scheme 
that is designed to remove basecalls associated with the B2 primer sequence would be 
appropriate for the HV1a amplicon, only if the amplicon was prepared and sequenced by 
itself.  This method of trimming has no ability to differentiate the origin of a read.  
Therefore, if this method of trimming were applied to data resulting from a pool of 
prepared CR amplicons, it would also remove good quality reads from HV1b, whose 
breath of sequence data spans the B2 primer binding region of the other amplicon.  This 
would also be true for the other primer binding regions which frame the overlapping CR 
amplicons (A2, C2, and D2). 
 Bidirectionality must also be considered.  If a particular base is observed in both 
mate pairs (the forward and reverse read) of an individual cluster, there is generally 
greater confidence in that call.  However, this greater confidence is not conveyed in the 
‘Generate Pileup’ function of SAMtools, which ignores mate pairs.  How this greater 
confidence should be accounted for has yet to be determined.  If bidirectionality is 
desirable, additional library purification steps using SPRI beads may reduce the range of 
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library length to 100-200 bp and increase the degree of overlap between mate pairs.  
However, these additional steps may lower the overall yield of the library and will likely 
affect cluster density. 
 Sites associated with NumtS were visually filtered from datasets produced in this 
project.  Developed bioinformatic pipelines should be able to identify reads that arise 
from NumtS, possibly by identifying reads which contain two or more NumtS variants.  
Once these reads are identified as NumtS, the read and its associated mate pair might be 
filtered from datasets during alignment.  Whether this can be done effectively without 
discarding reads of mtDNA origin is unknown.   
 All aforementioned caveats of the bioinformatics design, along with minimum 
coverage and Q-score cutoff for basecalling, affects the post-filtered coverage and base 
composition of reported positions.  This subsequently affects calculations of %MIN.  
Therefore, each variable should be considered if resultant calculations of %MIN are 
intended for the derivation of an interpretational limit of detection, above which, a 
mixture would be detected.  If this calculation uses a computational average of %MIN 
across many positions, the post-filtered coverage should be considered as it will give 
additional weight to the calculation of %MIN.  For example, a 2% variant that has 500X 
coverage may not be treated the same as 2% variant with 50,000X coverage. 
 Associating the coverage per base in post filtered data with the ability to identify 
all minor variants at the prescribed threshold may reveal an ideal cluster count per index 
needed for the detection of all minor variants.  Once a targeted post-filtered coverage per 
base is achieved, then targeting of a defined number of clusters per index can be tested.   
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Figure 23 – Correlation of the average coverage per base in the buccal mixture experiment with respect to the number of clusters in 
which sequence data was derived. 
 
Figure 24 – Correlation of the average coverage per base in the blood mixture experiment with respect to the number of clusters in 
which sequence data was derived. 
Depicted in Figure 23 and 24, are the average coverage per base calculations obtained 
from buccal and blood mixture experiments.  The plateau of the logarithmic regressions 
is low due to the limit induced by the computational pileup cap.   
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Section 5.6:  Overview of the tissue experiments and sequence variation 
 Deep sequence data derived from hair shaft amplicons shows a higher degree of 
sequence variation in Galaxy™ outputs and indicates that hairs may harbor a higher 
degree of sequence variation with respect to other tissue types.  These findings are 
consistent with earlier studies of hair shafts using Sanger sequencing methodologies 
(Wilson et al 1997).  In Table 19, the buccal swab from donor 001-CF30 shows two sites 
of variation greater than 1%.  These positions show comparable levels of variation to the  
 
Table 19 – First ten entries of Galaxy™ data for various samples from donor 001-CF30.  (Top left) Buccal reference.  (Center left) 
Hair A.  (Bottom left) Hair B.  (Top right) Hair C.  (Center right) Hair D.  (Bottom right) Hair E.  Gold = expected variant, Yellow = 
expected variation with %MIN >1%, Brown = expected variation showing a large degree of variation, Gray = unexpected variant with 
%MIN >1%. 
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Figure 25 – Visualization of aligned reads for 001-CF30 Hair E using IGV.  The position bound by brackets is 16092.  All aligned 
reads have been sorted with respect to the base composition at 16092. 
unmixed buccal reference in the first mixture experiment (Appendix 1).  Across the five 
hair samples collected from this donor, these positions vary in the degree of observed 
%MIN.  In four hairs (19a, b, d, e), the minor variant at position 185 is not observed.  
Interestingly, the minor variant at 16093 is near absent in one hair (19d, %MIN = 0.04) 
and shows a much larger degree of sequence variation in another (19e, %MIN = 43.55).  
Accompanied with the mixed sequence pattern at 16093 is the occurrence of a minor 
variant at 16092.  Remarkably, when the minor variant at 16092 is visualized using IGV 
(Figure 25), in all cases observed thus far, the 16092 variant appears to be accompanied 
with the cytosine residue in the neighboring 16093 position.   
 Additional observations of Galaxy™ outputs for hair sequence data indicated that 
NumtS were not recovered in any of the hair samples.  This is not unsurprising 
considering that the nuclear content of hair shafts are expected to be very low.  Hair 
sequence data also retained more positions from which to derivate %MIN after 
bioinformatic filtering (described as ‘sequence window’ in appendices 1-4) than those of 
blood and buccal experiments.  The explanation for this is unclear.  It is similarly unclear 
as to why the sequence data derived from two of the hair shafts prepared from donor 001-
CF30 were able to recover the distal 16390A variant (Appendix 3) which was 
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consistently absent in every buccal and blood experiment.  When this variant was 
recovered in hair sequence data however, it achieved less than 1,000X coverage. 
 Galaxy™ datasets from hair samples also contained more positions with minor 
variants greater than 1% relative to buccal reference material.  When the individual hairs 
are sorted by %MIN in descending order, several UVs are recovered (Appendices 3 and 
4).  Most of these UVs are not observed as variants within the buccal reference, so it is 
curious to see these in hair samples.  These minor variants also appear to be scattered 
randomly throughout the range of obtained sequence data so it is unclear whether this is a 
result of natural variation within the sample tissue, the additional cycles of PCR, or some 
combination thereof.  Without knowing the source of this variation, it is uncertain as to 
how a mixture detection threshold may need to account for this increased sequence 
variation. 
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ia
n
ts
 w
er
e 
n
o
t 
tr
ea
te
d
 a
s 
a 
si
te
 o
f 
ex
p
ec
te
d
 v
ar
ia
ti
o
n
. 
 U
n
ex
p
ec
te
d
 v
ar
ia
n
ts
 a
re
 p
o
si
ti
o
n
s 
in
 w
h
ic
h
 t
h
e 
ca
lc
u
la
te
d
 
m
in
o
r 
v
ar
ia
n
t 
w
as
 h
ig
h
er
 t
h
an
 a
n
 e
x
p
ec
te
d
 v
ar
ia
n
t.
  
A
rt
if
ac
t 
n
o
m
en
cl
at
u
re
: 
 N
 =
 v
ar
ia
ti
o
n
 a
t 
N
u
m
tS
 p
o
si
ti
o
n
s,
 S
C
 =
 a
li
g
n
m
en
t 
er
ro
rs
 i
n
d
u
ce
d
 b
y
 B
W
A
 s
o
ft
 c
li
p
p
in
g
 r
ea
d
s.
  
 
*
 =
 e
x
p
ec
te
d
 v
ar
ia
n
t 
1
6
3
9
0
 n
o
t 
co
v
er
ed
 i
n
 t
h
e 
se
q
u
en
ce
 w
in
d
o
w
 
†
 =
 u
n
ex
p
ec
te
d
 m
in
o
r 
v
ar
ia
n
t 
w
h
er
e 
th
e 
m
in
o
r 
ca
ll
 i
s 
in
 d
is
ag
re
em
en
t 
w
it
h
 t
h
e 
rC
R
S
 
‡
 =
 p
ri
m
e
r 
b
in
d
in
g
 v
a
ri
a
n
t 
 
§
 =
 e
xp
e
ct
e
d
 v
a
ri
a
n
ts
 1
6
3
5
2
 a
n
d
 1
6
3
5
7
 a
re
 n
o
t 
co
v
e
re
d
 i
n
 t
h
e
 s
e
q
u
e
n
ce
 w
in
d
o
w
 
ǂ
 =
 n
o
 v
a
ri
a
n
t 
re
p
o
rt
e
d
 a
t 
p
o
si
ti
o
n
 1
6
3
5
2
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A
p
p
en
d
ix
 2
 –
 S
u
m
m
ar
y
 o
f 
G
al
ax
y
™
 d
at
a 
fr
o
m
 t
h
e 
b
lo
o
d
 m
ix
tu
re
 e
x
p
er
im
en
t.
  
D
at
a 
w
as
 a
d
d
it
io
n
al
ly
 f
il
te
re
d
 i
n
 t
h
e 
sa
m
e 
m
an
n
er
 d
es
cr
ib
ed
 i
n
 A
p
p
en
d
ix
 1
. 
 S
N
P
s 
th
at
 
o
cc
u
rr
ed
 o
v
er
 N
u
m
tS
 p
o
si
ti
o
n
s 
w
er
e 
re
ta
in
ed
. 
 C
-s
tr
et
ch
 v
ar
ia
n
ts
 w
er
e 
n
o
t 
tr
ea
te
d
 a
s 
a 
si
te
 o
f 
ex
p
ec
te
d
 v
ar
ia
ti
o
n
. 
 A
d
d
it
io
n
al
 n
o
m
en
cl
at
u
re
: 
*
*
 =
 e
x
p
ec
te
d
 v
ar
ia
n
t 
1
6
3
9
0
 n
o
t 
co
v
er
ed
 i
n
 s
eq
u
en
ce
 w
in
d
o
w
—
n
o
 v
ar
ia
n
t 
re
p
o
rt
ed
 a
t 
ex
p
ec
te
d
 v
ar
ia
n
t 
2
9
5
 
₤
 =
 e
xp
e
ct
e
d
 v
a
ri
a
n
ts
 1
6
3
5
7
 n
o
t 
co
v
e
re
d
 i
n
 s
e
q
u
e
n
ce
 w
in
d
o
w
 
ǁ 
=
 p
a
ir
e
d
-e
n
d
 a
li
g
n
m
e
n
t 
fa
il
e
d
—
fo
rw
a
rd
 a
n
d
 r
e
v
e
rs
e
 r
e
a
d
s 
w
e
re
 a
li
g
n
e
d
 i
n
 s
in
g
le
-r
e
a
d
 a
li
g
n
m
e
n
t 
a
n
d
 r
e
su
lt
a
n
t 
B
A
M
 f
il
e
s 
w
e
re
 j
o
in
e
d
 
¶
 =
 n
o
 m
in
o
r 
v
a
ri
a
n
ts
 d
e
te
ct
e
d
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A
p
p
en
d
ix
 3
 –
 S
u
m
m
ar
y
 o
f 
G
al
ax
y
™
 d
at
a 
fr
o
m
 t
h
e 
fi
rs
t 
h
ai
r 
ti
ss
u
e 
ex
p
er
im
en
t.
  
D
at
a 
w
as
 a
d
d
it
io
n
al
ly
 f
il
te
re
d
 i
n
 t
h
e 
sa
m
e 
m
an
n
er
 d
es
cr
ib
ed
 i
n
 A
p
p
en
d
ix
 1
. 
 N
o
 S
N
P
s 
o
cc
u
rr
ed
 i
n
 e
it
h
er
 o
f 
th
e 
b
u
cc
al
 r
ef
er
en
ce
s 
o
v
er
 N
u
m
tS
 p
o
si
ti
o
n
s.
  
N
o
 N
u
m
tS
 v
ar
ia
n
ts
 w
er
e 
d
et
ec
te
d
 i
n
 h
ai
r 
d
at
a.
  
C
-s
tr
et
ch
 v
ar
ia
n
ts
 w
er
e 
n
o
t 
tr
ea
te
d
 a
s 
a 
si
te
 o
f 
ex
p
ec
te
d
 v
ar
ia
ti
o
n
. 
 A
d
d
it
io
n
al
 n
o
m
en
cl
at
u
re
: 
€
 =
 T
h
e
 u
n
e
xp
e
ct
e
d
 v
a
ri
a
n
t 
th
a
t 
o
cc
u
rs
 a
t 
p
o
si
ti
o
n
 1
6
0
9
2
 o
n
ly
 o
cc
u
rs
 i
f 
cy
to
si
n
e
 i
s 
p
re
se
n
t 
in
 p
o
si
ti
o
n
 1
6
0
9
3
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A
p
p
en
d
ix
 4
 –
 S
u
m
m
ar
y
 o
f 
G
al
ax
y
™
 d
at
a 
fr
o
m
 t
h
e 
se
co
n
d
 h
ai
r 
ti
ss
u
e 
ex
p
er
im
en
t.
  
D
at
a 
w
as
 a
d
d
it
io
n
al
ly
 f
il
te
re
d
 i
n
 t
h
e 
sa
m
e 
m
an
n
er
 d
es
cr
ib
ed
 i
n
 A
p
p
en
d
ix
 1
. 
 S
N
P
s 
th
at
 o
cc
u
rr
ed
 i
n
 t
h
e 
b
u
cc
al
 
re
fe
re
n
ce
s 
o
v
er
 N
u
m
tS
 p
o
si
ti
o
n
s 
w
er
e 
re
ta
in
ed
. 
 N
o
 N
u
m
tS
 v
ar
ia
n
ts
 w
er
e 
d
et
ec
te
d
 i
n
 h
ai
r 
d
at
a.
  
C
-s
tr
et
ch
 v
ar
ia
n
ts
 w
er
e 
n
o
t 
tr
ea
te
d
 a
s 
a 
si
te
 o
f 
ex
p
ec
te
d
 v
ar
ia
ti
o
n
. 
 S
eq
u
en
ce
 d
at
a 
p
ro
d
u
ce
d
 f
ro
m
 
th
e 
d
if
fe
re
n
t 
h
ai
rs
 o
f 
d
o
n
o
r 
5
 c
o
u
ld
 n
o
t 
b
e 
m
at
ch
ed
 t
o
 a
n
y
 r
ef
er
en
ce
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